ICPR 2022
The fifth edition of the Interdisciplinary Conference on Psychedelic Research.The 2022 Interdisciplinary Conference on Psychedelic Research (ICPR), held at the stunning Philharmonie in Haarlem, was a landmark event in the ongoing journey of psychedelic research. This conference, continuing the OPEN Foundation's tradition of fostering interdisciplinary dialogue, brought together a diverse group of experts and enthusiasts from around the globe.
Speakers
Sessions

Kirran Ahmad
Clinical Research Fellow / Anaesthetist, Centre for Psychedelic Research Imperial and Blessings of the Forest, United Kingdom

Maria Amato
Researcher, Health Screener & Practicum Training Coordinator, The Synthesis Institute, The Netherlands

Marco Aqil
Founder of APRA and PhD Candidate at the Spinoza Centre for Neuroimaging, The Netherlands

Judy Ashworth
Vice President, Chief Medical Officer, and Rx Strategic Services at Pinney Associates & CMO at Harm Reduction Theraputics, UCLA, United States

Matthew Baggott
Neuroscientist and CEO of Tactogen, United States

Michelle Baker Jones
Psychotherapeutic counsellor, Imperial College London, United Kingdom

Ilana Berlowitz
Clinical Researcher on Indigenous Psychoactive Use, University of Ben, Faculty of Medicine, Swritzerland

Michael Bogenschutz
Professor of Psychiatry & Director of the Langone Center for Psychedelic Medicine, NYU, United States

Julia Bornemann
PhD Candidate Researching Treatment of Chronic Pain using Psychedelics, Imperial College London, United States

Sander Bos
Multimedia Artist Reflecting the Psychedelic Experience by Leveraging New Technologies, The Netherlands

Bill Brennan
Psychologist and member of the Clinical Research team at Cybin Inc., NYU, United States

Florence Butlen-Ducuing
Clinical Psychiatrist & Scientific Senior Specialist in the Human Medicines Division, European Medicines Agency, The Netherlands

Graham Campbell
Trial Psychiatrist, Hammersmith Medicines Research (seconded from Small Pharma Ltd & collaborating with Imperial College London), United Kingdom

J. Christian Greer
Postdoctoral Fellow, Harvard University's Center for the Study of World Religions, United States

James Close
Researcher of Psychedelic drugs used in Pain Management and Fibromyalgia, Imperial College London, United Kingdom

Pedram Dara
Head of Operations at the OPEN Foundation and Conference Manager at ICPR 2022, The Earth

Corine de Boer
Chief Medical Officer, MD, PhD, MAPS Public Benefit Corporation, United States

Winston De La Haye
Consultant General & Addiction Psychiatrist, University Hospital of the West Indies, Jamaica

David Dupuis
Social Anthropologist and Clinical Psychologist (INSERM, Paris)

Erika Dyck
Professor and Canada Research Chair in the History of Health & Social Justice at the University of Saskatchewan

Emma Eckernäs
PhD student in Clinical Pharmacology, University of Gothenburg, Sweden

David Erritzoe
Clinical Senior Lecturer Consultant & Psychiatrist, Imperial College London, United Kingdom

Sonya Faber
Partner at Bioville Gmbh & MSL at Angelini Pharma. BoD member at Chacruna Institute, United States

Amanda Feilding
Founder and Executive Director of the Beckley Foundation, United Kingdom

George Fejer
Team Coordinator of the ALIUS group, University of Konstanz, Germany

Kate Godfrey
Post-Doctoral Researcher Leading the Implementation of EEG to Study Psychedelic Effects on the Brain, New Zealand

Ivar Goksøyr
Specialist in Clinical Psychology, Psykologvirke AS, Norway

Roland Griffiths
Professor in the Departments of Psychiatry and Neurosciences

Jeffrey Guss
Clinical Assistant Professor of Psychiatry, NYU School of Medicine, United States

Johanna Hilla Sopanen
Coordinator of Education & Training at Psychedelics Today, University of Exeter, United Kingdom

Aleksi Hupli
Sociologist and Member of the Drugs Expert Group of the Civil Society Forum on Drugs, Tampere University, Finland

Juuso Kähönen
Philosophy Researcher Exploring Self-Transcendence and Values. Helsinki University, Finland

Bernardo Kastrup
Executive Director of Essentia Foundation / Author, Philosopher, Computer Scientist, The Netherlands

Benjamin Kelmendi
Associate Research Scientist at the Department of Psychiatry, Yale University School of Medicine, United States

Maggie Kiraga
Director of Research at Qualified Citizen, University of Maastricht, Canada

Michael Kramer
Researcher of philosophy and phenomenology of psychedelic experiences, United States

Kim Kuypers
Associate Professor at Faculty of Psychology and Neuroscience

Ruben Laukkonen
Cognitive Neuroscientist, Vrije Universiteit Amsterdam, The Netherlands

Shayla Love
Senior Staff Writer at Vice Media, United States

Dino Luethi
Pharmacodynamics and Pharmacokinetics Reseracher, Switzerland

Drummond McCulloch
Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark

Mendel
Founder and CEO at Wavepaths, United Kingdom

Vincent Moon
Independent French Filmmaker & Radical Sound Explorer, France

Gitte Moos Knudsen
Professor at Rigshospitalet, University of Copenhagen, Denmark

Michael Mullette
COO at MAPS Public Benefit Corporation, United States

Roberta Murphy
Medical Psychotherapist, South West London at St. George's NHS Trust, Ireland

Ashleigh Murphy-Beiner
Clincal Psychologist Trainee, Imperial College London, United Kingdom

David Nichols
Founding President of the Heffter Research Institute / Professor Emeritus of Chemistry at Purdue University, United States

Tehseen Noorani
Senior Lecturer in Clinical & Community Psychology and Anthropology at the University of East London, United Kingdom

David Nutt
Professor of Neuropsychopharmacology and head of the Neuropsychopharmacology Unit in the Division of Brain Sciences, Department of Medicine, Imperial College London

Heval Özgen
Psychiatrist & Associate professor at LUMC

Brian Pace
Affiliate Scholar of the Center for Psychedelic Drug Research and Education at The Ohio State University, United States

S. Parker Singleton
Computational Biologist at Cornell University, United States

Torsten Passie
Professor of Psychiatry & Psychotherapy

Rotem Petranker
Co-Founder and Director of the Psychedelic Science Research Program, University of Toronto, Canada

Vince Polito
Senior Researcher in Cognitive Sciences and Member of the Bimolecular Discovery Research Centre, Macquarie University, Australia

Katrin Preller
Senior Researcher, Psychologist, and Neuroscientist at Yale University / University of Zurich, Switzerland

Charles Raison
Director of Clinical and Translational Research for Usona Institute. Director of Research on Spiritual Health for Emory Healthcare, United States

Jan Ramaekers
Professor and Head of the Psychopharmacology Department, Maastricht University, The Netherlands

Johannes Reckweg
Neuropsychology and Psychopharmacology, PhD Candidate at Maastricht University, The Netherlands

Joao Ribeiro
Founder of Liminal Minds and Associate Researcher at the Centre for Philosophy of Science of the University of Lisbon, Portugal

Dana Sawyer
Professor Emeritus of Philosophy and World Religions, Maine College of Art, United States

Emmanuelle Schindler
Assistant Professor of Neurology at Yale School of Medicine, United States

Jennifer Schmidt
Director of Preclinical Research and Development at Transcend Therapeutics, United States

Leonie Schneider

Carolina Seybert

Peter Sjöstedt-Hughes
Co-Founder of the Philosophy of Psychedelics Exeter Researcher Group, University of Exeter, Exeter, United Kingdom

Jordan Sloshower
Psychedelic Instructor, Yale University, Department of Psychiatry, United States

Meg Spriggs
Post Doctoral Researcher, Centre for Psychedelic Research, Imperial College London, United Kingdom

Paul Stamets
Founder of Fungi Perfecti and CEO of MycoMedica Life Sciences PBC, United States

Balazs Szigeti
Inventor of the "Self-Binding" Methodology, Imperial College London, United Kingdom

Jos ten Berge
Associate Professor in Art History at the VU University Amsterdam, The Netherlands

André van der Braak
Professor of Comparative Philosophy of Religion, Vrije Universiteit Amsterdam, The Netherlands

Vincent Verroust
PhD candidate in the history of science at the University of Picardie - Jules Vernes

Matthew Wall
Psychologist and Neuroscientist Specializing in fMRI's, Imperial College London, United Kingdom

Isabel Wießner
Neuroscientist investigating the effects of Ayahuasca & DMT on EEG brain activity, Federal University of Rio Grande do Norte, Germany

Monnica Williams
Research Chair for Mental Health Disparities, University of Ottawa. Principal Investigator for a multi-site study on MDMA-assisted psychotherapy for PTSD, Canada

David Yaden
Assistant Professor in the Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medcine, United States










































